West Paces Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27
| Closed | -$17.1K | – | 482 |
|
|
2025
Q1 | $17.1K | Hold |
27
| – | – | ﹤0.01% | 307 |
|
|
2024
Q4 | $19.2K | Hold |
27
| – | – | ﹤0.01% | 306 |
|
|
2024
Q3 | $28.4K | Hold |
27
| – | – | 0.01% | 280 |
|
|
2024
Q2 | $28.4K | Hold |
27
| – | – | 0.01% | 268 |
|
|
2024
Q1 | $26K | Buy |
27
+23
| +575% | +$22.1K | 0.01% | 287 |
|
|
2023
Q4 | $3.51K | Buy |
4
+2
| +100% | +$1.76K | ﹤0.01% | 432 |
|
|
2023
Q3 | $1.65K | Hold |
2
| – | – | ﹤0.01% | 436 |
|
|
2023
Q2 | $1.44K | Sell |
2
-1
| -33% | -$719 | ﹤0.01% | 468 |
|
|
2023
Q1 | $2.47K | Buy |
3
+1
| +50% | +$822 | ﹤0.01% | 457 |
|
|
2022
Q4 | $1.44K | Hold |
2
| – | – | ﹤0.01% | 455 |
|
|
2022
Q3 | $1.38K | Buy |
+2
| New | +$1.38K | ﹤0.01% | 452 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | -$1.4K | – | 603 |
|
|
2022
Q1 | $1.4K | Buy |
+2
| New | +$1.4K | ﹤0.01% | 507 |
|
|
2021
Q2 | – | Sell |
-40
| Closed | -$18.9K | – | 626 |
|
|
2021
Q1 | $18.9K | Buy |
+40
| New | +$18.9K | 0.01% | 271 |
|
|
2017
Q1 | – | Sell |
-22
| Closed | -$8.08K | – | 537 |
|
|
2016
Q4 | $8.08K | Buy |
+22
| New | +$8.08K | 0.01% | 360 |
|